SCHEMBL4936082

SCHEMBL4936082

Cc1ccc(C(=O)CN2CCCC2)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.75
KMT2A Q03164 2/20 0.75
ALDH1A1 P00352 6/20 0.64
USP2 O75604 1/20 0.59
ALPL P05186 1/20 0.57
ALPG P10696 1/20 0.57
HRH3 Q9Y5N1 2/20 0.55
CHRM2 P08172 1/20 0.55
ADRA2B P18089 1/20 0.55
DRD3 P35462 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
HTT P42858 1/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
HPGD P15428 1/20 0.55
NPSR1 Q6W5P4 1/20 0.54
LMNA P02545 1/20 0.54
MAOB P27338 2/20 0.53
NPC1 O15118 1/20 0.51
ALOX15 P16050 2/20 0.51
SLC6A4 P31645 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2616297 0.86 KMT2A (0.76) MEN1KMT2AALDH1A1ALPLLMNA
SCHEMBL14924456 0.86 MEN1 (1.00) MEN1KMT2AALDH1A1CHRM2HTT
SCHEMBL12947818 0.84 KMT2A (0.69) MEN1KMT2AALDH1A1HRH3HTT
SCHEMBL2616165 0.84 MEN1 (0.69) MEN1KMT2AALDH1A1USP2LMNA
Hydrochloric Acid SCHEMBL1495931 0.83 MEN1 (0.67) MEN1KMT2AALDH1A1USP2ALPL
SCHEMBL28484919 0.83 ALDH1A1 (0.73) MEN1KMT2AALDH1A1USP2HRH3
SCHEMBL1140551 0.82 ALDH1A1 (0.68) MEN1KMT2AALDH1A1USP2HRH3
SCHEMBL13316842 0.82 MEN1 (0.69) MEN1KMT2AALDH1A1HRH3CHRM2
SCHEMBL9871356 0.81 ALDH1A1 (0.61) MEN1KMT2AALDH1A1USP2ALPL
SCHEMBL1002669 0.81 ALDH1A1 (0.67) MEN1KMT2AALDH1A1ALPLALPG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080234498-A1 Pyrovalerone Analogues and Therapeutic Uses Thereof PRESIDENT AND FELLOW OF HARVARD COLLEGE (US) 2008-09-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080234498-A1 Pyrovalerone Analogues and Therapeutic Uses Thereof SLC6A2, SLC6A4, SLC6A3 MEN1 1560/4885KMT2A 3331/4885ALDH1A1 1868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.